ImpediMed Limited
IPDQF
$0.0445
$0.004812.09%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.44% | -1.76% | 6.04% | 10.93% | 14.73% |
| Total Depreciation and Amortization | 209.44% | 110.56% | 3.48% | -40.77% | -60.20% |
| Total Amortization of Deferred Charges | -15.16% | -15.16% | -15.16% | -8.61% | -0.44% |
| Total Other Non-Cash Items | -121.56% | -136.77% | -302.48% | 795.22% | 561.92% |
| Change in Net Operating Assets | 253.37% | 253.37% | 253.37% | 110.08% | 77.34% |
| Cash from Operations | -43.86% | -16.80% | 3.79% | 26.08% | 43.85% |
| Capital Expenditure | 100.00% | 87.51% | 79.95% | 51.89% | 9.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 58.38% | 52.45% | 47.91% | 27.54% | 2.98% |
| Cash from Investing | 60.38% | 54.45% | 49.99% | 28.97% | 3.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.86% | -5.39% | -12.24% | -46.66% | -113.76% |
| Issuance of Common Stock | -100.00% | -99.90% | -99.81% | 0.29% | 200,333.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 98.08% | 96.28% | 10.96% | -829.59% |
| Cash from Financing | -101.61% | -101.64% | -101.67% | -2.30% | 7,641.88% |
| Foreign Exchange rate Adjustments | 334.19% | 24.44% | -74.43% | -82.28% | -85.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -270.37% | -340.28% | -502.36% | 51.05% | 143.73% |
